EPC057 | Sustained HIV viral suppression among people living with HIV in Trinidad and Tobago | E-poster | Risk factors for acquisition, infectivity and transmission of HIV |
EPC058 | Spatio-temporal estimates of risk group proportions for adolescent girls and young women across 13 priority countries in sub-Saharan Africa | E-poster | Risk factors for acquisition, infectivity and transmission of HIV |
EPC059 | Female genital schistosomiasis and STI prevalence among at-risk women for HIV in Zambia | E-poster | Risk factors for acquisition, infectivity and transmission of HIV |
PESAC15 | Recent HIV acquisition and age-disparate relationships predict rapid repeated pregnancies among adolescent mothers in a large South African cohort | Poster exhibition | Risk factors for acquisition, infectivity and transmission of HIV |
PESAC16 | FCGR3Agene duplication, FcγRIIb-232TT and FcγRIIIb-HNA1a associate with an increased risk of vertical acquisition of HIV-1 | Poster exhibition | Risk factors for acquisition, infectivity and transmission of HIV |
EPD042 | Factors associated with viral non-suppression among HIV positive children and adolescents enrolled to the orphans and vulnerable program in Uganda | E-poster | Role of social and behavioural science in biomedical responses |
EPD043 | Three-year follow-up of PositiveLinks: higher use of mHealth platform associated with sustained viral suppression | E-poster | Role of social and behavioural science in biomedical responses |
PEMOD75 | PrEParados: a spatially explicit network visualization framework to identify Latino MSM who qualify for PrEP use | Poster exhibition | Role of social and behavioural science in biomedical responses |
EPF048 | Healthcare and social assistance for the social protection of people with HIV/AIDS in situations of vulnerability: the Brazilian case | E-poster | Safe housing, social protection and other care and support for people affected by HIV |
EPA087 | Limited immunogenicity of SARS-CoV-2 vaccine in people living with HIV (PWH) and low nadir CD4 counts | E-poster | SARS-Cov2 vaccines |